Focus Partners Advisor Solutions’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469K | Buy |
6,703
+24
| +0.4% | +$1.68K | 0.01% | 698 |
|
|
2025
Q1 | $491K | Buy |
6,679
+1,642
| +33% | +$121K | 0.01% | 591 |
|
|
2024
Q4 | $330K | Sell |
5,037
-1,057
| -17% | -$69.3K | 0.01% | 579 |
|
|
2024
Q3 | $475K | Buy |
6,094
+1,938
| +47% | +$151K | 0.01% | 464 |
|
|
2024
Q2 | $324K | Sell |
4,156
-2,631
| -39% | -$205K | 0.01% | 472 |
|
|
2024
Q1 | $460K | Buy |
6,787
+2,579
| +61% | +$175K | 0.01% | 377 |
|
|
2023
Q4 | $283K | Buy |
4,208
+1,003
| +31% | +$67.6K | 0.01% | 337 |
|
|
2023
Q3 | $217K | Buy |
+3,205
| New | +$217K | 0.01% | 410 |
|